Shukra Pharmaceuticals P/B Ratio
Shukra Pharmaceuticals (SHUKRAPHAR) P/B ratio is 16.15 (High), book value per share ₹20.45 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see SHUKRAPHAR share price.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SHUKRAPHAR P/B Ratio — Valuation Insights & Book Value Analysis
Shukra Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 16.15 (High). Review SHUKRAPHAR P/E ratio to evaluate earnings-based valuation against sector peers.
- Stock appears overvalued with PB of 16.15, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1243.6% above historical average
- Trading at premium to sector average PB of -0.31
Shukra Pharmaceuticals P/B Ratio Historical Trend
SHUKRAPHAR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View SHUKRAPHAR 52-week chart for the annual high/low range and current price position.
SHUKRAPHAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Shukra Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.55 | ₹20.45 | ₹31.72 | ₹90 | Moderate |
| 2025 | 4.14 | ₹14.32 | ₹59.25 | ₹63 | High |
| 2024 | 0.26 | ₹52.73 | ₹13.65 | ₹58 | Low |
| 2023 | 0.05 | ₹62.5 | ₹3.10 | ₹25 | Low |
| 2022 | 0.01 | ₹80.0 | ₹0.70 | ₹16 | Low |
SHUKRAPHAR vs Healthcare Peers — P/B Ratio Comparison
Shukra Pharmaceuticals P/B 16.15 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |